SMC Spain

SMC Spain

SMC Spain
Cargo
Topics

EMA recommends not to approve lecanemab against Alzheimer's disease

The European Medicines Agency (EMA) has recommended not granting marketing authorization for Leqembi™ (lecanemab) for the treatment of Alzheimer's disease. The EMA's Committee for Medicinal Products for Human Use (CHMP) considers that its effect in delaying cognitive decline does not outweigh the risk of serious side effects associated with the drug, in particular swelling and possible bleeding in patients' brains. Leqembi™ was approved in 2023 in the United States.

0

Recombinant shingles vaccine linked to lower risk of dementia

After the introduction of a shingles vaccine (Zostavax) in 2006, several studies suggested that the risk of dementia might be lower in people who had received the vaccine, although the results were inconclusive. In many countries Zostavax has been withdrawn and replaced by a much more effective vaccine (Shingrix). A study published today in Nature Medicine suggests that this new recombinant shingles vaccine, Shingrix, is associated with a greater reduction in the risk of dementia compared to Zostavax and vaccines against other types of infections.

 

0

Review concludes that studies on the benefits of moderate drinking use biased methods

Studies associating the consumption of low amounts of alcohol with health benefits are not of good scientific quality, says a meta-analysis pooling the findings of 107 previous papers. For example, studies may use a reference group of older adults who have given up or limited alcohol for health reasons. Compared to those who continue to drink, the latter appear to be in better health, notes the article, published in the Journal of Studies on Alcohol and Drugs.

0

Tiny organoids help repair liver damage in mice

Japanese scientists have developed tiny liver organoids from stem cells that, transplanted into mice, integrate with the original organ and help repair fibrotic lesions. This scar-like tissue damage is common to many liver diseases, such as fatty liver disease and cirrhosis. According to the authors, who publish their results in the journal Science Translational Medicine, such organoids could offer an alternative to liver transplants in the future.

0

Trees capture methane from micro-organisms that inhabit their bark

The surface of tree bark plays an important role in the elimination of methane gas from the atmosphere thanks to the microorganisms that live on it, according to a study published today in Nature in which CREAF participates. Methane is one of the gases responsible for the greenhouse effect. The authors estimate that this process, unknown until now, makes trees 10% more beneficial to the climate than previously thought.

0

AI models trained on AI-generated data can crash

Using artificial intelligence (AI)-generated datasets to train future generations of machine learning models can contaminate their results, a concept known as ‘model collapse’, according to a paper published in Nature. The research shows that, within a few generations, original content is replaced by unrelated nonsense, demonstrating the importance of using reliable data to train AI models.

0

How Wildfires and Saharan Dust Affect Hospitalizations for Psychological Disorders

A team led by the Carlos III Health Institute has analyzed how short-term concentrations of particles associated with wildfires and Saharan dust incursions influence hospital admissions in Spain due to mental and behavioral disorders. The results were explained in a briefing organized by the Science Media Centre Spain. 

 

0

Correlation between prenatal diet and autism diagnosis in children analyzed

A healthy diet during pregnancy is associated with a lower likelihood of children being diagnosed with autism or communication difficulties, according to a study. The research team did not find a correlation between prenatal diet and repetitive and restricted behaviors (characteristic of these disorders). The analysis is published in JAMA Network Open and gathers data from more than 96,000 mother-child pairs in England and Norway.

0

Potential of GLP-1 drugs to treat diseases beyond obesity explored

A paper published today in the journal Science explores the potential of glucagon-like peptide-1 (GLP-1)-based drugs such as semaglutide to treat diseases beyond diabetes and obesity. For example, recent studies suggest that they could improve conditions ranging from depression to neurological disorders to cardiovascular and kidney disease.

0